The tweet was deleted by the author.
But we saved everything 🙂.
Eli Lilly breaks ground on new Goochland facility as stock rises 3.4%
Eli Lilly announced it has started construction on its second U.S. manufacturing facility in two months, expanding its capacity for cancer drug production and planning 650 new high-wage jobs in Goochland, Virginia. The stock is up 3.4% on the day at $1,315.
LLY price prediction
Current price:
$1,413.35
39.65
2.89%
Closed
10/30
Daily range
1409.19
1436.72
1436.72
Weekly range
1273.89
1436.72
1436.72
Loading...
Highlights
- Eli Lilly has started building a new Virginia facility to produce next-generation cancer drugs and create 650 high-wage jobs.
- 96 of 118 analysts rate Eli Lilly stock a buy, with a median price target of $1,385, about 5.3% above current levels.
- Eli Lilly stock is up 3.4% on the day at $1,315.
Eli Lilly stated it has recently broken ground at its second U.S. facility in two months as part of a continuing expansion of its domestic manufacturing capabilities. The new site in Goochland, Virginia is planned as the future home for next-generation cancer medicine production. The company expects to bring 650 high-wage jobs to the region as a result of this facility.
View post on X Loading...
New weekly high as bullish structure meets overbought signals
Price is sitting right at support from the prior weekly high at $1,311, having just pushed through that area to set a new high for the week. Shares of Eli Lilly remain above the MA-20, MA-50, and MA-200, which keeps the daily chart structure bullish. RSI at 66.1 is nearing overbought territory, an early sign that the recent advance is becoming stretched.
Upside odds stand out as traders await a range breakout
To gauge whether the recent move higher is being accepted, traders should watch for a close above the recent range. Price has moved above the weekly high at $1,311, marking a new high for the week. Over the next five trading days, upside probability stands at 78% and downside probability at 22%, with an expected trading range between $1,283 and $1,347. Still, the advance over the past week remains emerging and not yet confirmed. A close above the recent range would show buyers are willing to follow through, while a drop below $1,311 would indicate the move is being faded. On the weekly chart, the longer-term picture stays firmly constructive.
Previously it was reported that Eli Lilly delivered positive Phase 3 clinical data in pediatric ulcerative colitis, supporting a constructive long-term outlook for the company. The latest expansion into cancer drug manufacturing adds a new dimension to the growth narrative, with traders now monitoring price action above $1,311 for signs of a sustained breakout.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Latest Eli Lilly News
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
